Gamasutra: The Art & Business of Making Gamesspacer
View All     RSS
October 24, 2014
arrowPress Releases
October 24, 2014
PR Newswire
View All





If you enjoy reading this site, you might also want to check out these UBM Tech sites:


Cygames invests over $600k in Japanese indie game Airship Q
January 27, 2014 | By Alex Wawro




Newsbrief: Rage of Bahamut developer Cygames invested 70 million yen (roughly $681k USD or 413k) in Japanese indie studio Miracle Positive earlier this month in an effort to help improve and expand its sandbox action RPG Airship Q.

According to a report from Siliconera, Miracle Positive had already raised 1.2 million yen -- more than twice its funding goal -- for development of Airship Q on Makuake, a Japanese crowdfunding site. The influx of cash from Cygames will afford Miracle Positive the opportunity to add new content to the game, including multiplayer systems and mid-bosses.

Designed for the PlayStation Vita, Airship Q is a sandbox action RPG in which anthropomorphic cats mine materials, craft equipment and pilot airships in a 2D world akin to that of Terraria or Starbound. The game was also an IGF entrant this year, though it wasn't nominated for an award.



Related Jobs

Yoh
Yoh — Vancouver, British Columbia, Canada
[10.24.14]

Build & Test Engineer
The College of New Jersey
The College of New Jersey — Ewing, New Jersey, United States
[10.24.14]

Assistant Professor - Interactive Multi Media - Tenure Track
Bohemia Interactive Simulations
Bohemia Interactive Simulations — Prague, Czech Republic
[10.24.14]

Game Designer
Next Games
Next Games — Helsinki, Finland
[10.24.14]

Senior Level Designer










Comments


Christian Nutt
profile image
I don't know the circumstances, of course, but it's interesting to see a social game firm cross the streams, so to speak -- it looks like this company which has made so much money off of (to generalize) "cow clickers" has now decided that the other lucrative spot of the industry is Minecraft-alikes (again, to generalize.)


none
 
Comment: